Efficacy of zafirlukast in the treatment of patients with bronchial asthma

Journal of Microbiology, Immunology and Infection

Volumn 34, Issue 1, 2001, Pages 63-70

  Tsai, J J ^a   Chan, S C ^a   Ho, C K ^a   Su, Y C ^a   Feng, T C ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Asthma; Zafirlukast

Indexed keywords

AMINOPHYLLINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; ZAFIRLUKAST;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GROUPS BY AGE; HUMAN; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; AGED; AMINOPHYLLINE; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 0035050082     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Leukotrienes are potent constrictors of human bronchi
2. Leukotrienes in the pathogenesis of asthma
3. Combined antagonism of leukotrienes and histamine produces predominate inhibition of allergen induced early and late phase airway obstruction in asthmatics
4. Effect of zafirlukast (Accolate) on cellular mediators of inflammation: Bronchoalveolar lavage fluid findings after segmental antigen challenge
5. Zafirlukast: A review of its pharmacology and therapeutic potential in the management of asthma
6. Effect of treatment with zafirlukast (Accolate) on bronchial hyperresponsiveness in patients with mild to moderate asthma
7. Airway and systemic effects of inhaled corticosteroids in asthma: Dose response relationship
8. The effect of inhaled fluticasone propionate 100 μg bd compared with oral zafirlukast 20 mg bd on bronchial hyperresponsiveness in mild to moderate asthmatic
9. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma
10. Leukotrienes are potent constrictors of human bronchi
11. The effect of inhaled leukotriene D4 in humans
12. Airway responsiveness to leukotriene C4 and D4 and to methacholine in patients with asthma and normal controls
13. Urinary leukotriene E4 after exercise challenge in children with asthma
14. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist
15. Zafirlukast in clinical practice results of the Accolate clinical experience and pharmacoepidemiology trial (ACCEPT) in patients with asthma